Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22910
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLiberopoulos, E. N.en
dc.contributor.authorFlorentin, M.en
dc.contributor.authorKei, A.en
dc.contributor.authorMountzouri, E.en
dc.contributor.authorAgouridis, A.en
dc.contributor.authorElisaf, M. S.en
dc.date.accessioned2015-11-24T19:28:36Z-
dc.date.available2015-11-24T19:28:36Z-
dc.identifier.issn1751-7176-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22910-
dc.rightsDefault Licence-
dc.subjectAnalysis of Varianceen
dc.subjectBiological Assayen
dc.subjectBlood Glucose/*metabolismen
dc.subjectDiabetes Mellitus, Type 2/*diagnosis/metabolism/physiopathologyen
dc.subjectFasting/*metabolism/physiologyen
dc.subjectFemaleen
dc.subjectHealth Status Indicatorsen
dc.subjectHemoglobin A, Glycosylated/*analysisen
dc.subjectHumansen
dc.subjectHyperglycemia/*diagnosis/metabolism/physiopathologyen
dc.subjectInsulin Resistanceen
dc.subjectMaleen
dc.subjectMetabolic Syndrome X/*physiopathologyen
dc.subjectMiddle Ageden
dc.subjectStatistics, Nonparametricen
dc.titleComparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L)en
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1111/j.1751-7176.2010.00318.x-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20629819-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1111/j.1751-7176.2010.00318.x/asset/j.1751-7176.2010.00318.x.pdf?v=1&t=h0m77p2q&s=9567df8dccac1e7d515a92127d3fe2ff331fa5d9-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2010-
heal.abstractThe aim of this study was to compare hemoglobin A(1c) (HbA(1c)) and fasting glucose for the diagnosis of diabetes among people with metabolic syndrome and fasting glucose >100 mg/dL (5.5 mmol/L). Consecutive individuals (N=142) with metabolic syndrome and fasting glucose >100 mg/dL (5.5 mmol/L) but without a self-reported history of diabetes who visited the outpatient lipid and obesity clinic of the University Hospital of Ioannina, Greece from January through September 2009 were included. HbA(1c)> or =6.5% and fasting glucose > or =126 mg/dL (7 mmol/L) were used separately to define diabetes. Overall, 29.5% of patients had both HbA(1c)> or =6.5% and fasting glucose > or =126 mg/dL (7 mmol/L), 25.3% had HbA(1c)> or =6.5% but fasting glucose <126 mg/dL (7 mmol/L), and 9.1% had HbA(1c) <6.5% but fasting glucose > or =126 mg/dL (7 mmol/L). A greater proportion of patients reached a diagnosis of diabetes based on the HbA(1c) criterion (n=78, 54.9%) compared with the fasting glucose criterion (n=55, 38.7%, P=.000). A large proportion of patients (44.8%) with impaired fasting glucose (fasting glucose 100-125 mg/dL; 5.6-6.9 mmol/L) would be classified as diabetics using the HbA(1c) criterion. Implication of the HbA(1c) criterion may increase the rate of diabetes diagnosis among people with metabolic syndrome and fasting glucose >100 mg/dL (5.5 mmol/L).en
heal.journalNameJ Clin Hypertens (Greenwich)en
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Liberopoulos-2010-Comparison of hemogl.pdf211.44 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons